vs

Side-by-side financial comparison of Eos Energy Enterprises, Inc. (EOSE) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $58.0M, roughly 1.4× Eos Energy Enterprises, Inc.). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -207.7%, a 169.6% gap on every dollar of revenue. On growth, Eos Energy Enterprises, Inc. posted the faster year-over-year revenue change (699.6% vs 20.2%).

Eos Energy Enterprises, Inc. is an energy storage solutions provider that designs, produces and deploys safe long-duration zinc-based battery systems. It serves utility, commercial, industrial and microgrid customers across North America, Europe and Asia, supporting grid stability and renewable energy integration.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

EOSE vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$58.0M
EOSE
Growing faster (revenue YoY)
EOSE
EOSE
+679.4% gap
EOSE
699.6%
20.2%
PRCT
Higher net margin
PRCT
PRCT
169.6% more per $
PRCT
-38.1%
-207.7%
EOSE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
EOSE
EOSE
PRCT
PRCT
Revenue
$58.0M
$83.1M
Net Profit
$-120.5M
$-31.6M
Gross Margin
-93.8%
64.9%
Operating Margin
-140.1%
-4.1%
Net Margin
-207.7%
-38.1%
Revenue YoY
699.6%
20.2%
Net Profit YoY
55.1%
-27.9%
EPS (diluted)
$-0.53
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOSE
EOSE
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$58.0M
$76.4M
Q3 25
$30.5M
$83.3M
Q2 25
$15.2M
$79.2M
Q1 25
$10.5M
$69.2M
Q4 24
$7.3M
$68.2M
Q3 24
$58.4M
Q2 24
$53.4M
Net Profit
EOSE
EOSE
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-120.5M
$-29.8M
Q3 25
$-641.4M
$-21.4M
Q2 25
$-222.9M
$-19.6M
Q1 25
$15.1M
$-24.7M
Q4 24
$-268.1M
$-18.9M
Q3 24
$-21.0M
Q2 24
$-25.6M
Gross Margin
EOSE
EOSE
PRCT
PRCT
Q1 26
64.9%
Q4 25
-93.8%
60.6%
Q3 25
-111.2%
64.8%
Q2 25
-203.2%
65.4%
Q1 25
-234.7%
63.9%
Q4 24
-324.0%
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
EOSE
EOSE
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-140.1%
-40.6%
Q3 25
-200.6%
-27.8%
Q2 25
-419.1%
-28.0%
Q1 25
-506.2%
-39.7%
Q4 24
-712.8%
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
EOSE
EOSE
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-207.7%
-39.1%
Q3 25
-2102.1%
-25.7%
Q2 25
-1463.2%
-24.7%
Q1 25
144.7%
-35.8%
Q4 24
-3696.7%
-27.6%
Q3 24
-35.9%
Q2 24
-48.0%
EPS (diluted)
EOSE
EOSE
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.53
$-0.54
Q3 25
$-4.91
$-0.38
Q2 25
$-1.05
$-0.35
Q1 25
$-0.20
$-0.45
Q4 24
$-2.30
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOSE
EOSE
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$568.0M
$245.6M
Total DebtLower is stronger
$813.3M
$51.7M
Stockholders' EquityBook value
$-2.2B
$347.7M
Total Assets
$885.2M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOSE
EOSE
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$568.0M
$286.5M
Q3 25
$58.7M
$294.3M
Q2 25
$120.2M
$302.7M
Q1 25
$82.6M
$316.2M
Q4 24
$74.3M
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
EOSE
EOSE
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$813.3M
$51.6M
Q3 25
$448.5M
$51.6M
Q2 25
$445.3M
$51.5M
Q1 25
$325.5M
$51.5M
Q4 24
$316.9M
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
EOSE
EOSE
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$-2.2B
$365.9M
Q3 25
$-2.3B
$380.3M
Q2 25
$-1.1B
$385.8M
Q1 25
$-942.2M
$389.2M
Q4 24
$-1.1B
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Total Assets
EOSE
EOSE
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$885.2M
$508.1M
Q3 25
$328.2M
$511.5M
Q2 25
$361.0M
$513.1M
Q1 25
$263.3M
$519.4M
Q4 24
$260.3M
$534.0M
Q3 24
$374.1M
Q2 24
$374.4M
Debt / Equity
EOSE
EOSE
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOSE
EOSE
PRCT
PRCT
Operating Cash FlowLast quarter
$-50.3M
Free Cash FlowOCF − Capex
$-75.2M
FCF MarginFCF / Revenue
-129.7%
Capex IntensityCapex / Revenue
43.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-265.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOSE
EOSE
PRCT
PRCT
Q1 26
Q4 25
$-50.3M
$-10.3M
Q3 25
$-65.9M
$-6.6M
Q2 25
$-66.1M
$-15.0M
Q1 25
$-28.9M
$-17.0M
Q4 24
$-42.7M
$-32.4M
Q3 24
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
EOSE
EOSE
PRCT
PRCT
Q1 26
Q4 25
$-75.2M
$-12.2M
Q3 25
$-82.7M
$-9.5M
Q2 25
$-73.2M
$-17.8M
Q1 25
$-33.8M
$-18.8M
Q4 24
$-55.8M
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
EOSE
EOSE
PRCT
PRCT
Q1 26
Q4 25
-129.7%
-15.9%
Q3 25
-271.1%
-11.4%
Q2 25
-480.2%
-22.5%
Q1 25
-323.6%
-27.2%
Q4 24
-769.1%
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
EOSE
EOSE
PRCT
PRCT
Q1 26
Q4 25
43.1%
2.4%
Q3 25
55.2%
3.4%
Q2 25
46.2%
3.5%
Q1 25
47.0%
2.7%
Q4 24
180.6%
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
EOSE
EOSE
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
-1.91×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOSE
EOSE

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons